Long-term survivors of human immunodeficiency virus (
HIV) infection have been shown to have a greatly increased incidence of
B cell lymphomas. This increased lymphomagenesis suggests some link between
HIV infection and the destabilization of the host B cell genome, a phenomenon also suggested by the extraordinary high frequency of mutation, insertion, and deletion in the broadly neutralizing
HIV antibodies. Since HIV does not infect B cells, the molecular mechanisms of this
genomic instability remain to be fully defined. Here, we demonstrate that the cell membrane-permeable HIV Tat
proteins enhance
activation-induced deaminase (AID)-mediated somatic hypermutation (SHM) of antibody V regions through their modulation of the endogenous polymerase II (Pol II) transcriptional process. Extremely small amounts of Tat that could come from bystander HIV-infected cells were sufficient to promote SHM. Our data suggest HIV Tat is one missing link between
HIV infection and the overall B cell
genomic instability in
AIDS patients.IMPORTANCE Although the introduction of antiretroviral
therapy (ART) has successfully controlled primary effects of human immunodeficiency virus (
HIV) infection, such as HIV proliferation and HIV-induced immune deficiency, it did not eliminate the increased susceptibility of HIV-infected patients to
B cell lymphomas. We find that a secreted HIV
protein, Tat, enhances the intrinsic antibody diversification mechanism by increasing the AID-induced somatic mutations at the heavy-chain variable (VH) regions in human B cells. This could contribute to the high rate of mutation in the variable regions of broadly neutralizing anti-
HIV antibodies and the genomewide mutations leading to B cell
malignancies in HIV carriers.